HIV 1 VPR INDUCES G2 CELL CYCLE ARREST AND APOPTOSIS
HIV 1 VPR 诱导 G2 细胞周期停滞和凋亡
基本信息
- 批准号:2745185
- 负责人:
- 金额:$ 24.58万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1995
- 资助国家:美国
- 起止时间:1995-07-18 至 2003-04-30
- 项目状态:已结题
- 来源:
- 关键词:HeLa cells apoptosis cell cycle cysteine endopeptidases enzyme inhibitors flow cytometry gene mutation human immunodeficiency virus 1 human immunodeficiency virus 2 molecular pathology protein structure function simian immunodeficiency virus site directed mutagenesis tissue /cell culture virus infection mechanism virus protein
项目摘要
The HIV-1 gene product is a 96 amino acid protein, which is important
for viral replication and likely to be critical for HIV-1 pathogenesis.
Vpr is expressed following infection of cells and is also found packaged
in virions. In 1995, the PI was among the first to describe a novel
phenotype of the Vpr protein whereby cells infected by HIV-1 expressing
Vpr undergo arrest at the G2 phase of the cell cycle. They subsequently
published that cell cycle arrest induced by Vpr is followed by apoptosis
of the arrested cells. Recently, they found that not only does de novo
expression of Vpr induce cell cycle arrest, but Vpr packaged into
virions is capable of inducing cell cycle arrest when introduced into
cells following infection. Vpr has been shown to augment virus
production and one potential function of Vpr is to prevent T-cell clonal
expansion in response to antigens thus suppressing an early step in
establishing an effective immune response. Therefore, Vpr may be a
critical determinant for pathogenic features of HIV-1 disease and
further understanding of Vpr mechanisms of action may facilitate the
development of therapeutic agents directed against Vpr.
Damage to cell DNA by irradiation or chemical modification can lead to
arrest at multiple points in the cell cycle including the so-called G2
checkpoint. Failure to repair the damage can lead to apoptosis.
According to the PI, Vpr is the only gene product known to induce such
an efficient cell cycle arrest in mammalian cells at G2. Thus, an
understanding of the mechanism of action of Vpr will also be important
in understanding the signal transduction pathways which lead to arrest
at the G2 checkpoint in mammalian cells. Previously, the PI generated
a considerable amount of preliminary data about Vpr action, developed
a number of unique assays for assessment of Vpr function and developed
reagents which will allow him to effectively carry forward further
studies on the mechanism of Vpr action. The specific aims are: Aim 1.
To further characterize cell cycle arrest by HIV-1 Vpr. Aim 2. To
further characterize Vpr mediated apoptosis Aim 3. To identify cellular
factors involved in Vpr-mediated cell cycle arrest and apoptosis.
HIV-1基因产物是一个96个氨基酸的蛋白质,这是很重要的
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
IRVIN S.Y. CHEN其他文献
IRVIN S.Y. CHEN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('IRVIN S.Y. CHEN', 18)}}的其他基金
(Attack)2: Genetic engineering of cellular and humoral immunity to cure HIV
(攻击)2:细胞和体液免疫基因工程治愈艾滋病毒
- 批准号:
10468647 - 财政年份:2020
- 资助金额:
$ 24.58万 - 项目类别:
(Attack)2: Genetic engineering of cellular and humoral immunity to cure HIV
(攻击)2:细胞和体液免疫基因工程治愈艾滋病毒
- 批准号:
10614633 - 财政年份:2020
- 资助金额:
$ 24.58万 - 项目类别:
(Attack)2: Genetic engineering of cellular and humoral immunity to cure HIV
(攻击)2:细胞和体液免疫基因工程治愈艾滋病毒
- 批准号:
10160814 - 财政年份:2020
- 资助金额:
$ 24.58万 - 项目类别:
(Attack)2: Genetic engineering of cellular and humoral immunity to cure HIV
(攻击)2:细胞和体液免疫基因工程治愈艾滋病毒
- 批准号:
9890819 - 财政年份:2020
- 资助金额:
$ 24.58万 - 项目类别:
相似国自然基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
- 批准号:LBY21H010001
- 批准年份:2020
- 资助金额:0.0 万元
- 项目类别:省市级项目
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
- 批准号:81703335
- 批准年份:2017
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
- 批准号:81670594
- 批准年份:2016
- 资助金额:58.0 万元
- 项目类别:面上项目
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
- 批准号:81470791
- 批准年份:2014
- 资助金额:73.0 万元
- 项目类别:面上项目
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
- 批准号:81301123
- 批准年份:2013
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
- 批准号:81101529
- 批准年份:2011
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
- 批准号:39500043
- 批准年份:1995
- 资助金额:9.0 万元
- 项目类别:青年科学基金项目
相似海外基金
The role of the RO60 (TROVE2) autoantigen in modulating cell-cycle progression, apoptosis and chemo-resistance in cancer cells
RO60 (TROVE2) 自身抗原在调节癌细胞的细胞周期进程、细胞凋亡和化疗耐药中的作用
- 批准号:
234333147 - 财政年份:2013
- 资助金额:
$ 24.58万 - 项目类别:
Research Grants
Downregulation o fserine/arginine-rich splicing factor 3 induces G1 cell cycle arrest and apoptosis in colon cancer cells
富含丝氨酸/精氨酸的剪接因子 3 的下调诱导结肠癌细胞 G1 细胞周期停滞和凋亡
- 批准号:
23590943 - 财政年份:2011
- 资助金额:
$ 24.58万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The Cellular Stress Response in Cold-adapted Organisms: Building Novel Mechanistic Links between Heat Stress, Cell Cycle Arrest and Apoptosis in Antarctic Fishes.
适应寒冷的生物体的细胞应激反应:在南极鱼类的热应激、细胞周期停滞和细胞凋亡之间建立新的机制联系。
- 批准号:
0944743 - 财政年份:2010
- 资助金额:
$ 24.58万 - 项目类别:
Standard Grant
Cell cycle and apoptosis analysis of synergistic and antagonistic anti-cancer drug conbinations
协同和拮抗抗癌药物组合的细胞周期和凋亡分析
- 批准号:
358574-2007 - 财政年份:2009
- 资助金额:
$ 24.58万 - 项目类别:
Industrial Research Fellowships
DNA repair, Cell cycle Checkpoints and Apoptosis and Bladder Cancer Risk
DNA 修复、细胞周期检查点和细胞凋亡以及膀胱癌风险
- 批准号:
8065522 - 财政年份:2009
- 资助金额:
$ 24.58万 - 项目类别:
DNA repair, Cell cycle Checkpoints and Apoptosis and Bladder Cancer Risk
DNA 修复、细胞周期检查点和细胞凋亡以及膀胱癌风险
- 批准号:
7661914 - 财政年份:2009
- 资助金额:
$ 24.58万 - 项目类别:
DNA repair, Cell cycle Checkpoints and Apoptosis and Bladder Cancer Risk
DNA 修复、细胞周期检查点和细胞凋亡以及膀胱癌风险
- 批准号:
8268502 - 财政年份:2009
- 资助金额:
$ 24.58万 - 项目类别:
DNA repair, Cell cycle Checkpoints and Apoptosis and Bladder Cancer Risk
DNA 修复、细胞周期检查点和细胞凋亡以及膀胱癌风险
- 批准号:
7848344 - 财政年份:2009
- 资助金额:
$ 24.58万 - 项目类别:
Cell Cycle/Apoptosis Gene Variants and Breast Cancer Risk
细胞周期/凋亡基因变异和乳腺癌风险
- 批准号:
8075439 - 财政年份:2008
- 资助金额:
$ 24.58万 - 项目类别: